- Issuer ticker
-
AXSM
- Reported as of
-
17 Nov 2021
- Net transaction value
-
+$113,922
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
19 Nov 2021, 06:30:28 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Mark E Saad
Key filing fact
Mark E. Saad filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 19 Nov 2021.
Key facts
- This page summarizes Mark E. Saad's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Nov 2021, 06:30.
Change
- Previous filing in this sequence was filed on 08 Jun 2021.
- Current net transaction value: +$113,922.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXSM
transaction
Common Stock
Purchase
- Transaction value
- $103,597
- Shares
- +3,000
- Change %
- +43%
- Price
-
$34.53
- Shares after
- 10,002
- Date
- 17 Nov 2021
- Ownership
- Direct
AXSM
transaction
Common Stock
Purchase
- Transaction value
- $3,440
- Shares
- +100
- Change %
- Price
-
$34.40
- Shares after
- 100
- Date
- 17 Nov 2021
- Ownership
- Custodial account for child
- Footnotes
- F1
AXSM
transaction
Common Stock
Purchase
- Transaction value
- $3,445
- Shares
- +100
- Change %
- Price
-
$34.45
- Shares after
- 100
- Date
- 17 Nov 2021
- Ownership
- Custodial account for child
- Footnotes
- F1
AXSM
transaction
Common Stock
Purchase
- Transaction value
- $3,440
- Shares
- +100
- Change %
- Price
-
$34.40
- Shares after
- 100
- Date
- 17 Nov 2021
- Ownership
- Custodial account for child
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote